The largest database of trusted experimental protocols

15 protocols using iopromide 370

1

Multi-Modal CT Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The patients were scanned with a first-generation dual-source CT (Somatom Definition Flash, Siemens Healthcare, Forchheim, Germany), or a second-generation dual-source CT (Somatom Definition Flash); or 640-slice CT (Toshiba Aquilion ONE, Toshiba, Otawara, Japan), with corresponding 20 patients (40%) for 64-slice CT, 15 patients (30%) for 128-slice CT, and 15 patients (30%) for 640-slice CT, respectively. The imaging protocol has been previously described in detail.21 (link) Intravenous contrast medium (Iopromide 370, Bayer Schering Pharma, Guangzhou, China) was administered during each scan with details described in our previous study.21 (link) Images were reconstructed with a slice thickness of 0.6 to 0.75 mm and a reconstruction interval of 0.5 to 0.6 mm for the first- and second-generation dual-source CT, slice thickness of 0.5 mm and reconstruction interval of 0.25 mm for 640-slice CT, respectively.
Although data were acquired with different CT scanners, our previous study did not show any significant difference in the diagnostic value between different multislice CT vendors.21 (link) Therefore, this study analysis is considered comparable between the different vendors.
+ Open protocol
+ Expand
2

Transradial Coronary Angiography Technique

Check if the same lab product or an alternative is used in the 5 most similar protocols
As shown in the literature [9 (link), 10 (link)], standard transradial techniques were used for angiography. Lidocaine was used as the local anesthesia. The right radial artery was cannulated using a 21-gauge needle and a transradial kit with a 30-centimeter- (cm) long, 6-French (F) introducer (Terumo, Tokyo, Japan). With the introducer in place, 200 μg nitroglycerin and 2000 IU heparin were introduced into the side port of the sheath. If the operation lasted for more than 1 hour, another dose of heparin (1000 IU/h) was administered intravenously. A 5 F multipurpose catheter (Terumo, Tokyo, Japan) 130 cm long was alternatively used for selective angiography using standard techniques. Briefly, the catheter tip was placed on the orifice of the target artery (the left or the right coronary artery) and introduced with a 0.035″ hydrophilic guide wire (Terumo, Tokyo, Japan). We used iopromide 370 (Bayer, Bayer Schering Pharma, Germany) to take magnified angiography images at different angles. If the angiography failed when using the 5 F multipurpose catheter, the 6 F Judkins catheters (J6F, Cordis Corporation, USA) or 6 F pig catheters (Cordis Corporation, USA) would be used instead. If the radial artery was too small or too circuitous for catheters to manipulate, the femoral artery would be used instead.
+ Open protocol
+ Expand
3

Chest CT Imaging Protocol for Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chest CT images were acquired using a 64 detector-row CT scanner (LightSpeed VCT, GE, USA) with following parameters (Table 1): collimation = 128 × 0.625 mm, gantry rotation time = 350 ms, pitch = 1.2, field of view = 360 mm × 300 ~ 360 mm, matrix size = 512 × 512. The tube voltage was 120 kVp in Cohorts 1 and 3, and 100 kVp in Cohort 2. Images were reconstructed as 1.25-mm thick slices (+ 1-mm interslice gap) and 5-mm thick slices (+ 5-mm interslice gap), respectively. A soft-tissue convolution kernel of B31f was used. Participants in Cohort 3 first underwent non-ECG-gated chest NCCT image acquisition and then, to acquire the chest CECT image, they were intravenously administered a bolus of contrast medium (Iopromide 370, Bayer Schering Pharma AG; dosage = 1 ml/kg body weight, rate = 3 ml/s) followed by a flush of normal saline (30 ml). Then the chest CECT image was acquired at the arterial phase and venous phase, respectively. Coverage in all chest CT datasets extended from the thoracic inlet to the upper abdomen, at a minimum.
+ Open protocol
+ Expand
4

Coronary CTA Protocol for Single-Heartbeat Imaging

Check if the same lab product or an alternative is used in the 5 most similar protocols
All coronary CTA scans were acquired with a 320 slice GE Revolution scanner (GE Healthcar) enabling to image the heart in one heartbeat. This protocol used a single-rotation axial scan with prospective gating, 16-cm detector coverage, noise index 30 (noise level fixed over all kVp levels and body sizes), and gantry rotation time of 0.28 s. Tube potential ranged between 70 and 120 kV depending on body size. Iodinated contrast agent was administered with Iopromide 370 (Bayer Schering Pharma) using the bolus tracking method at a rate of 5.0 ml/s depending on body size. The volume of iodinated contrast injected was individualised according to body size (50–80 mL). Beta-blockers were administered when necessary to obtain a target heart rate of < 60 beats/min. According to guidelines [14 (link)], sublingual nitrates (two sprays of 0.8 mg) were administered 5 min prior to CT scanning in all patients. The images were reconstructed at 75 ± 10% of the R-R interval.
+ Open protocol
+ Expand
5

Contrast-Enhanced CTA of Brain Vasculature

Check if the same lab product or an alternative is used in the 5 most similar protocols
Similar to a previous study [16 (link)], all patients underwent CTA scanning from the aortic arch to vertex using the Discovery CT750 HD scanner (HDCT, GE Healthcare, Milwaukee, WI, USA). Briefly, non-enhanced CT brain scan was first performed, which was followed by contrast enhanced CTA. CTA images were acquired when contrast agent (Iopromide 370, Bayer Schering Pharma AG) at the dose of 1.0 ml/kg was injected at a rate of 5 ml/s followed by IV injection of saline chase of 40 ml at a rate of 5 ml/s. A bolus tracking method (Smart Prep) was used to monitor the optimal contrast enhancement. Study parameters included the caudo-cranial scan direction, 120 kVp, rotation time of 0.5 s, 50cm × 50cm DFOV (Display Field Of View), 0.625 mm construction thickness at 0.625 mm intervals, and helical pitch of 0.984:1.
+ Open protocol
+ Expand
6

Rosuvastatin and Iopromide Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rosuvastatin calcium tablets were purchased from AstraZeneca Pharmaceuticals Co., Ltd.(China), and Iopromide 370 was from Bayer Pharmaceuticals with an iodine content of 370 mg/mL (50 mL/bottle).
+ Open protocol
+ Expand
7

Contrast-Enhanced CT Imaging Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Philips Brilliance iCT Scanner (Royal Dutch Philips Electronics Ltd, Amsterdam, The Netherlands) and GE LightSpeed VCT® (GE Healthcare, Milwaukee, WI, USA) were used for CECT examinations. Non-ionic ICM were intravenously injected by a high-pressure injector (Ulrich Medical® Inc., Ulm, Germany). The injection doses and injection rates of ICM were adopted according to our institutional protocol [16 (link)]. The ICM used included Iodixanol 270 (GE Healthcare, London, UK), Ioversol 320 (Jiangsu Hengrui Medicine Co., Ltd, Jiangsu, China), Iodixanol 320 (Jiangsu Hengrui Medicine Co., Jiangsu, China), Iohexol 350 (Yangtze River Pharmaceutical Co., Ltd, Jiangsu, China), Iopamidol 350 (Bracco, Milan, Italy), Iobitridol 350 (Guerbet, Paris, France), and Iopromide 370 (Bayer Healthcare, Leverkusen, Germany).
+ Open protocol
+ Expand
8

Pharmacological Agents for Preclinical Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ketamine was obtained from Jiangsu Hengrui Medicine Co., Ltd. Droperidol was purchased from Shanghai Xudong Haipu Pharmaceutical Co., Ltd. Iopromide 370 was purchased from Bayer AG. Evans blue dye was purchased from Sigma-Aldrich (Merck KGaA).
+ Open protocol
+ Expand
9

Comprehensive Cerebrovascular Imaging Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 298 patients completed CTA or MRA, of which 84 patients were scanned on a GE 3.0T MR scanner (Discovery MR 750 System, GE Healthcare, Milwaukee, WI, USA) with an 8-channel head coil. 3D Time-of-flight MRA was obtained using TR/TE = 19/3.4 ms, FOV = 31.4 × 22 cm, thickness = 1.2 mm, matrix = 256 × 256, and NEX = 1, number of slices = 160. Two hundred fourteen patients underwent CTA scanning from the aortic arch to vertex with the Discovery CT750 HD scanner (HDCT, GE Healthcare, Milwaukee, WI, USA). In brief, non-enhanced CT brain scan was first performed, followed by contrast enhanced CTA. The CTA images were obtained when contrast agent (Iopromide 370, Bayer Schering Pharma AG) with a dose of 1.0 ml/kg was injected at a rate of 5 ml/s, followed by 40 ml of saline chase injected intravenously at a rate of 5 ml/s. Standard 3-dimensional CT angiography scanning parameters were used. The slice thickness was 0.63 mm, section interval was 0.3 mm, the helical pitch was 1, 26.8 cm × 25 cm DFOV (display field of view), 80 kVp and 400 mAs, rotation time of 0.5 s.
+ Open protocol
+ Expand
10

Contrast-enhanced CT Imaging Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
GE LightSpeed VCT® (GE Healthcare, Milwaukee, WI) and Philips Brilliance iCT Scanner (Royal Dutch Philips Electronics Ltd, Amsterdam, The Netherlands) were used for CT scanning. Nonionic iodinated contrast media were intravenously injected by a high-pressure injector (Ulrich Medical® Inc.). The ICM used included Iopromide 370 (Bayer Healthcare), Iodixanol 270 (GE Healthcare), Ioversol 320 (Jiangsu Hengrui Medicine Co., Ltd), Iohexol 350 (Yangtze River Pharmaceutical Co., Ltd), Iopamidol 350 (Bracco), Iobitridol 350 (Guerbet), and Iodixanol 320(Jiangsu Hengrui Medicine Co., Ltd). The injection doses and rates of ICM were selected according to patient weight and the purpose of CT examinations, based on our institutional protocol (Additional file 1: Table S1).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!